StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Business UpdateJun 23, 2026, 08:36 AM

Microbot Medical's LIBERTY System adopted by first PA academic center

AI Summary

Microbot Medical Inc. announced that a globally recognized academic center in Pennsylvania has adopted its LIBERTY® Endovascular Robotic System, marking the first adoption in the state. This expands the company's presence to seven states across the Eastern U.S. The company also plans to expand its sales territory to the West Coast and into U.S. federal healthcare systems.

Key Highlights

  • LIBERTY® Endovascular Robotic System adopted by first academic center in Pennsylvania.
  • Expands Microbot Medical's presence to seven states across the Eastern U.S.
  • New customer operates multiple hospitals and multispecialty centers in PA and NJ.
  • Company plans to expand sales territory to the West Coast.
  • Agreement to expand LIBERTY System access to U.S. federal healthcare systems.